Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

67.56 +0.05 (+0.08%)
Streaming Delayed Price Updated: 11:54 AM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
34 35 Next >
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
From Bristol Myers Squibb
Via Business Wire
Bristol-Myers Squibb's Debt Overview
Shares of Bristol-Myers Squibb (NYSE:BMY) increased by 8.89% in the past three months. Before having a look at the importance of debt, let us look at how much debt Bristol-... 
Via Benzinga
Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan’s 40th Annual Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
Weakness Is Turning Into Opportunity For Bristol Myers Squibb
With plenty of strong catalysts, shares of BMY are just beginning to pivot higher. 
Via Talk Markets
7 Pharmaceutical Stocks That Could Make You Rich
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich 
Via InvestorPlace
Bristol Myers Squibb to Present at J.P. Morgan’s 40th Annual Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
53 Firms Going Ex-Dividend Next Week, Including Comcast, AT&T And General Mills
There are several well known large cap stocks going ex-dividend next week including nine of our Top 100 Dividend Stocks. 
Via Talk Markets
Best Stocks for 2022: Bristol-Myers Squibb Will Offer Huge Returns
Bristol-Myers Squibb offers a substantial dividend, but that's far from the only reason that BMY stock is a great investment for 2022. 
Via InvestorPlace
7 Dividend Increases Expected In January 2022
How many dividend increases are you going to receive this month? How many stocks on this list do you own? Are you ready to crush it in 2022? 
Via Talk Markets
Market Trend: Erratic And Unreliable
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is. 
Via Talk Markets
Peering Into Bristol-myers Squibb Company's Recent Short Interest
Bristol-myers Squibb Company's (NYSE:BMY) short percent of float has risen 14.13% since last its last report. The company recently reported that it has 23.26 million shares sold... 
Via Benzinga
Best Stocks For Wheel Strategy Trades: Use These In 2022
Blue chips companies, high dividend stocks, REITs, and low beta ETFs work well when employing the wheel strategy. 
Via Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to... 
Via FinancialNewsMedia
Exposures Product Safety
Buy Time: Dirt Cheap, Pays A Market-Beating Yield, And Just Announced A $15 Billion Share Buyback
The US stock market’s resilience is amazing. It started off November with a hard dip in response to the Omicron variant news. 
Via Talk Markets
Dreaming Of A Red Christmas
The stock market is reacting with lots of selling to the weekend's news. 
Via Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some... 
Via Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: 
Via Benzinga
Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022
From Bristol Myers Squibb
Via Business Wire
FDA Approves Bristol Myers' Orencia As First Drug To Prevent Graft-Versus-Host Disease
The FDA approved Bristol Myers Squibb & Co's (NYSE: BMY) Orencia (abatacept) for the prevention of acute graft-versus-host disease (GVHD) in combination... 
Via Benzinga
U.S. Food and Drug Administration Approves Orencia® (abatacept) in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Acute Graft Versus Host Disease (aGvHD)...
From Bristol Myers Squibb
Via Business Wire
CNBC's Final Trades: Darden Restaurants, Bristol-Myers Squibb, AIG, And This Stock Which Is The Biggest Breakout
On CNBC’s “H... 
Via Benzinga
3 Stocks That Can Make You Rich in Just a Few Years
Investing in the most popular stocks on the Street won't make investors rich in a few years. To accomplish that goal, a contrarian spirit is needed. 
Via InvestorPlace
To sell or not to sell?
Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho 
Via Talk Markets
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401
From Bristol Myers Squibb
Via Business Wire
Biotech Playbook 2021: No Help From Small Caps In Q4
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but... 
Via Talk Markets
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
Sanofi SA (NASDAQ: SNY) and Johnson & Johnson (NYSE: JNJ) posted new data from their myeloma therapies, Sarclisa and Darzalex, respectively. Data were shared at... 
Via Benzinga
Why Bristol-Myers Squibb Shares Are Rising Today
Bristol-Myers Squibb Co (NYSE: BMY) is trading higher Monday after the company announced an additional $15 billion buyback and raised its quarterly dividend. Bristol-Myers... 
Via Benzinga
As We Come Towards The End Of The Trading Year, A Round Up Of Four Recent Stocks
As we come towards the end of another trading year I thought it would be a good idea to catch up on some of the more recent stocks I have analyzed and in no particular order. 
Via Talk Markets
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
34 35 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.